Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma.
about
Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cellsA bioinformatic assay for pluripotency in human cellsIdentifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression dataA meta-analysis of multiple matched copy number and transcriptomics data sets for inferring gene regulatory relationships.Chromobox homolog 2 protein: A novel biomarker for predicting prognosis and Taxol sensitivity in patients with breast cancer.Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinomaGenomic profiling by whole-genome single nucleotide polymorphism arrays in Wilms tumor and association with relapse.Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcomeStructure and mechanisms of lysine methylation recognition by the chromodomain in gene transcription.Gene expression profiles in stage I uterine serous carcinoma in comparison to grade 3 and grade 1 stage I endometrioid adenocarcinoma.Cyclin B2 and p53 control proper timing of centrosome separationTranscriptional response in normal mouse tissues after i.v. (211)At administration - response related to absorbed dose, dose rate, and timeProteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer.Investigating inter-chromosomal regulatory relationships through a comprehensive meta-analysis of matched copy number and transcriptomics data setsMiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5.Prognostic factor analysis for breast cancer using gene expression profiles.MINT: a multivariate integrative method to identify reproducible molecular signatures across independent experiments and platformsTranscriptional response of BALB/c mouse thyroids following in vivo astatine-211 exposure reveals distinct gene expression profiles.Circadian rhythm influences genome-wide transcriptional responses to (131)I in a tissue-specific manner in mice.Multivariate hypergeometric similarity measure.Non-targeted transcriptomic effects upon thyroid irradiation: similarity between in-field and out-of-field responses varies with tissue type.Integrative genomics with mediation analysis in a survival context.Priming increases the anti-tumor effect and therapeutic window of 177Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1Sushi Domain-Containing Protein 3: A Potential Target for Breast Cancer.Genetic variation and gastric cancer risk: a field synopsis and meta-analysis.Hedgehog inhibitor sonidegib potentiates 177Lu-octreotate therapy of GOT1 human small intestine neuroendocrine tumors in nude miceThe overexpression and prognostic role of DCAF13 in hepatocellular carcinoma.Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole exome sequencing.High expression of UBE2C is associated with the aggressive progression and poor outcome of malignant glioma.Expression array analysis of the hepatocyte growth factor invasive program.Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing.Differential gene expression in human fibroblasts after alpha-particle emitter (211)At compared with (60)Co irradiation.Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells.MetaKTSP: a meta-analytic top scoring pair method for robust cross-study validation of omics prediction analysis.Frequent MYC coamplification and DNA hypomethylation of multiple genes on 8q in 8p11-p12-amplified breast carcinomas.Functional proteomics outlines the complexity of breast cancer molecular subtypes.Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma.Expression of SCUBE2 gene declines in high grade endometrial cancer and associates with expression of steroid hormone receptors and tumor suppressor PTEN.Genomic profiles and CRTC1-MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma.Robust microarray meta-analysis identifies differentially expressed genes for clinical prediction.
P2860
Q24319134-3E289EF2-52AE-49F1-B32B-3DB4704EEAB4Q30484872-4F2FB868-4262-4FAB-8CA8-61B13C759012Q30587051-7A663048-E7B3-4ACA-A7BA-0E38ADF2312DQ30844284-D5AE08DA-705F-465F-BFD5-939B77615D12Q33597544-B82AB313-B61C-4A89-B832-5A00EFFAB237Q33653747-70313AAD-FC50-44D1-A444-7C4C3E0B833DQ34190897-493108AE-196A-4ED2-985B-FF32CD1E8B91Q34530428-DCC0758A-D2B6-4B34-BF1F-E71EE6A2221DQ34709022-6E01A139-0C09-4141-AF2C-E9CC11D2381FQ34713009-87CD25D8-9C51-427B-992D-D60A853BF02CQ35232617-6763F415-A5BF-4DCE-B9EE-610ED25AF853Q35261291-0FCDFD9D-F19A-4BF9-8F6F-720B4EAE182FQ35313220-1A1C9B5E-D4E8-4D5A-8787-4DC525F091A2Q35845694-BBE42D54-E23F-4A89-9DE6-372527A8B3B3Q35955237-0CD81233-9506-435C-B579-690850D47E62Q36084643-4D62A3A9-EB8D-4644-8339-7598C220D368Q36292006-64D8A148-A02F-4216-A177-8DF9BCF15CA9Q36372946-48A31DDD-0ED7-4552-B4C1-C5B29AF86518Q36373469-BF2ADEF5-07B3-47CB-AEBB-AF3D4F6448F4Q37172268-D7F6167C-7B23-4138-A011-3516277CA12AQ37364071-7C8380E2-C8F6-45CE-B45A-04762418BC78Q37426230-4C6250CA-242D-4BD9-8B2C-80A7E50E74A0Q37590508-F6176DD0-D62B-425D-9F1B-89605E60D9B0Q38306311-21AA0436-E73D-4CF5-AC9A-E73D3B8FB436Q38366774-42D10B71-924F-40EE-A640-0B2F1779B632Q38430202-C7D02ECF-01E5-4A4A-B918-796621A5BF3DQ38432256-E02DB42D-7358-4A7F-8016-199DB7DF9741Q38616932-77E2ED77-19F4-4535-A8F7-55B18B8633E8Q38721719-AC337CE4-7B1E-4EF3-BF0E-A72E6391C2E3Q38847534-9A9B3726-F282-40E3-8BD1-8433601FA31FQ39076259-C2BF4503-F7A6-4B0C-A3A7-815A1AD47D28Q39248375-44910FF4-1D52-42B4-AE4D-552EB2A7EBFDQ39398132-CCDC28DF-BE1A-41D6-B304-53ECDA62E51DQ39788006-49442F4A-8679-4288-B1F4-D0A96D348782Q40058161-13368A1F-9D29-4693-A6C2-8F3BE9C4EC2CQ41564586-3907BEFC-FA44-4128-AA2D-0CD56D9E39CDQ44502455-E7B6D45A-F457-4EB6-AA70-22297C94138BQ45042162-6C56975C-F7BE-4EB7-99A8-9D505C95CC1EQ45136830-E55E7C0D-669D-4DCC-AE4C-1C32B03E6CF0Q51272263-67679F53-D82A-44CA-BC0E-01F2A760FFEE
P2860
Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Clinical implications of gene ...... s in diploid breast carcinoma.
@en
Clinical implications of gene ...... s in diploid breast carcinoma.
@nl
type
label
Clinical implications of gene ...... s in diploid breast carcinoma.
@en
Clinical implications of gene ...... s in diploid breast carcinoma.
@nl
prefLabel
Clinical implications of gene ...... s in diploid breast carcinoma.
@en
Clinical implications of gene ...... s in diploid breast carcinoma.
@nl
P2093
P1476
Clinical implications of gene ...... s in diploid breast carcinoma.
@en
P2093
Anikó Kovács
Elin Möllerström
Ghita Fallenius
Khalil Helou
Per Karlsson
Szilárd Nemes
Toshima Z Parris
Ulla Delle
P304
P356
10.1158/1078-0432.CCR-10-0889
P407
P577
2010-06-15T00:00:00Z